Rivaroxaban may be as effective as warfarin for bioprosthetic mitral valves, AF
The primary results from the RIVER Trial, Rivaroxaban for Valvular Heart disease and Atrial Fibrillation, show that rivaroxaban is comparable to warfarin, which is currently the standard of care anticoagulant prescribed for ...
Nov 16, 2020
0
1